[Microeletrode guided stereotactic pallidotomy and pallido-thalamotomy for treatment of Parkinson's disease].
OBJECTIVE: Authors evaluated the therapeutic effect of the MRI and microelectrodeguided stereotactic pallido- and pallido-thalamotomy in 33 patients with Parkinson's disease (PD), whose symptoms were refractory to pharmacological therapy. MATERIAL AND METHODS: The patients were evaluated according to the internationally standardized rating scales (UPDRS part II, III, Schawb & England, Hoehn & Yahr, and Fahn) at six timepoints: before the operation, and 2 days, 3, 6, 9 and 12 months postoperatively. The patients were divided into 2 groups. Those in group A had relief of all main parkinsonian symptoms after pallidotomy including tremor. The patients in group B had no relief of tremor after pallidotomy. For them the pallidotomy was completed by thalamotomy in the same sitting, which had resulted in cessation of tremor. RESULTS: The following results were obtained by using the UPDRS part III: after pallidotomy "On state" mean: preoperative 51.2, postoperative at 2nd day 29.5 at 3, 6 and 9th month 26, and at 12th month 28.7. "Off state" mean: preoperative 64.3, postoperative at 2nd day 31.6, at 3, 6 and 9th month 26, and at 12th months 30.5. After pallidothalamotomy "On state" mean: preoperative 43.5, postoperative at 2nd day 27.9, at 3rd month 22.9, at 6th month 22.8, and at 9 and 12th month 24.5. "Off state" mean: preoperative 62.6, postoperative at 2nd day 38, at 3rd month 30, at 6th month 31,8 and at 9 and 12th month 33.8. CONCLUSIONS: For those patients, whose tremor was not successfully controlled by pallidotomy, the combined pallido-thalamotomy was effective. The clinical symptomps, according to the rating scales, improved significantly in both groups (student t: P<0.0001), but bilateral lesioning carried higher surgical morbidity.